Newsroom
Montefiore in the News
No Reductions in IBD Hospitalizations, Surgeries After Infliximab Approval in Canada
- June 18, 2019
Dr. Thomas Ullman, chief, Gastroenterology, Montefiore, and professor, Medicine, Einstein, discusses how the first biologic therapy approved for inflammatory bowel disease in Canada did not lead to lower rates of hospitalizations or intestinal surgeries for the disorder in Ontario.
